These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9989484)

  • 1. Role of cytokines in multiple myeloma.
    Anderson KC; Lust JA
    Semin Hematol; 1999 Jan; 36(1 Suppl 3):14-20. PubMed ID: 9989484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraproteinaemias: pathophysiology.
    Samson D
    Schweiz Med Wochenschr; 2000 Nov; 130(44):1643-8. PubMed ID: 11103434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma.
    Gadó K; Domján G; Hegyesi H; Falus A
    Cell Biol Int; 2000; 24(4):195-209. PubMed ID: 10816321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenetic relation between monoclonal gammopathies of undetermined significance and multiple myeloma.
    Greipp PR; Lust JA
    Stem Cells; 1995 Aug; 13 Suppl 2():10-21. PubMed ID: 8520496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights in the clinical biology of multiple myeloma.
    Bataille R
    Semin Hematol; 1997 Jan; 34(1 Suppl 1):23-8. PubMed ID: 9122743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of human and viral cytokines in the pathogenesis of multiple myeloma.
    Berenson JR; Sjak-Shie NN; Vescio RA
    Semin Cancer Biol; 2000 Oct; 10(5):383-91. PubMed ID: 11100886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Korać P; Peran I; Skrtić A; Ajduković R; Kristo DR; Dominis M
    Pathol Int; 2009 May; 59(5):354-8. PubMed ID: 19432679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monoclonal gammopathy of undetermined significance].
    Chaïbi P; Merlin L; Thomas C; Piette F
    Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
    Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
    Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines and signal transduction.
    Hideshima T; Podar K; Chauhan D; Anderson KC
    Best Pract Res Clin Haematol; 2005; 18(4):509-24. PubMed ID: 16026734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients.
    Rettig MB; Ma HJ; Vescio RA; Põld M; Schiller G; Belson D; Savage A; Nishikubo C; Wu C; Fraser J; Said JW; Berenson JR
    Science; 1997 Jun; 276(5320):1851-4. PubMed ID: 9188529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiology of multiple myeloma: what's new.
    Berenson JR
    Semin Oncol; 1999 Oct; 26(5 Suppl 13):2-9. PubMed ID: 10528889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progression.
    Kline M; Donovan K; Wellik L; Lust C; Jin W; Moon-Tasson L; Xiong Y; Witzig TE; Kumar S; Rajkumar SV; Lust JA
    Leuk Res; 2007 May; 31(5):591-8. PubMed ID: 16879867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM
    Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma.
    Barillé S; Bataille R; Amiot M
    Eur Cytokine Netw; 2000 Dec; 11(4):546-51. PubMed ID: 11125296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of IGF-1, VEGF, IL-6 in multiple myeloma progression].
    Guo YQ; Chen SL
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):231-4. PubMed ID: 16875552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human herpesvirus 8 (KSHV) contamination of peripheral blood and autograft products from multiple myeloma patients.
    Vescio RA; Wu CH; Zheng L; Sheen D; Ma H; Liu J; Stewart AK; Ballester O; Noga SJ; Rugo H; Freytes C; Stadtmauer E; Sahebi F; Tarantolo S; Stiff P; Schiller GJ; White M; Jacobs C; DiPersio J; Anderson KC; Berenson JR
    Bone Marrow Transplant; 2000 Jan; 25(2):153-60. PubMed ID: 10673673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Leleu X; Le Friec G; Facon T; Amiot L; Fauchet R; Hennache B; Coiteux V; Yakoub-Agha I; Dubucquoi S; Avet-Loiseau H; Mathiot C; Bataille R; Mary JY;
    Clin Cancer Res; 2005 Oct; 11(20):7297-303. PubMed ID: 16243800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma.
    Yasui H; Hideshima T; Richardson PG; Anderson KC
    Br J Haematol; 2006 Feb; 132(4):385-97. PubMed ID: 16412014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
    Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
    Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.